Fixed-dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
Version 2 2020-03-09, 09:44Version 2 2020-03-09, 09:44
Version 1 2020-03-09, 09:32Version 1 2020-03-09, 09:32
figure
posted on 2020-03-09, 09:44authored bySanjay Asrani, Jason Bacharach, Edward Holland, Hayley McKee, Huan Sheng, Richard A. Lewis, Casey C. Kopczynski, Theresa Heah
Article full
text
The article associated with this page has been accepted for
online publication and is in the final stages of production. The link to the
full text will be made available on this page in the next few days.
The above summary slide and plain language summary represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).